132 related articles for article (PubMed ID: 1804631)
1. Effect of angiotensin converting enzyme inhibitors on cardiac noradrenaline release.
Richardt G; Kranzhöfer R; Schömig A
Eur Heart J; 1991 Dec; 12 Suppl F():121-3. PubMed ID: 1804631
[TBL] [Abstract][Full Text] [Related]
2. Role of angiotensin and sodium intake in cardiac noradrenaline release.
Richardt G; Mayer E; Schömig A
Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):297-301. PubMed ID: 1961256
[TBL] [Abstract][Full Text] [Related]
3. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
Carlsson L; Abrahamsson T
Eur J Pharmacol; 1989 Jul; 166(2):157-64. PubMed ID: 2792189
[TBL] [Abstract][Full Text] [Related]
4. Captopril and ramiprilat protect against free radical injury in isolated working rat hearts.
Pi XJ; Chen X
J Mol Cell Cardiol; 1989 Dec; 21(12):1261-71. PubMed ID: 2698963
[TBL] [Abstract][Full Text] [Related]
5. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
[TBL] [Abstract][Full Text] [Related]
6. Facilitation by procaterol, a beta-adrenoceptor agonist, of noradrenaline release in the pithed rat independently of angiotensin II formation.
Kotsonis P; Majewski H
Br J Pharmacol; 1994 Nov; 113(3):781-8. PubMed ID: 7858867
[TBL] [Abstract][Full Text] [Related]
7. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498.
van Gilst WH; de Graeff PA; Wesseling H; de Langen CD
J Cardiovasc Pharmacol; 1986; 8(4):722-8. PubMed ID: 2427810
[TBL] [Abstract][Full Text] [Related]
8. Effect of ACE-inhibitor ramiprilat and AT1-receptor antagonist candesartan on cardiac norepinephrine release: comparison between ischemic and nonischemic conditions.
Richardt D; Wolfrum S; Büttner C; Schäfer U; Dendorfer A; Kurz T; Richardt G
J Cardiovasc Pharmacol; 2002 Oct; 40(4):641-6. PubMed ID: 12352328
[TBL] [Abstract][Full Text] [Related]
9. Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation.
van Gilst WH; Scholtens E; de Graeff PA; de Langen CD; Wesseling H
Circulation; 1988 Jun; 77(6 Pt 2):I24-9. PubMed ID: 3286044
[TBL] [Abstract][Full Text] [Related]
10. Kinetic properties of the angiotensin converting enzyme inhibitor ramiprilat.
Bünning P
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S31-5. PubMed ID: 2485060
[TBL] [Abstract][Full Text] [Related]
11. Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
Zhang X; Dunham EW; Zimmerman BG
J Hypertens; 1995 Dec; 13(12 Pt 1):1413-19. PubMed ID: 8866903
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibition unmasks the sympathofacilitatory effect of bradykinin in human right atrium.
Rump LC; Berlit T; Schwertfeger E; Beyersdorf F; Schollmeyer P; Bohmann C
J Hypertens; 1997 Nov; 15(11):1263-70. PubMed ID: 9383175
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of the action of angiotensin-converting enzyme inhibitors on agonist-induced Ca2+ influx.
Zhu Z; Tepel M; Neusser M; Zidek W
J Vasc Res; 1994; 31(5):265-70. PubMed ID: 7522595
[TBL] [Abstract][Full Text] [Related]
14. Effect of angiotensin converting enzyme inhibitors on the vasoconstrictor action of angiotensin I on isolated rat kidney.
Schmidt M; Giesen-Crouse EM; Krieger JP; Welsch C; Imbs JL
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S100-5. PubMed ID: 2438482
[TBL] [Abstract][Full Text] [Related]
15. Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia.
Richardt G; Waas W; Kranzhöfer R; Mayer E; Schömig A
Circ Res; 1987 Jul; 61(1):117-23. PubMed ID: 3608108
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin B2-receptor-mediated stimulation of exocytotic noradrenaline release from cardiac sympathetic neurons.
Kurz T; Tölg R; Richardt G
J Mol Cell Cardiol; 1997 Sep; 29(9):2561-9. PubMed ID: 9299378
[TBL] [Abstract][Full Text] [Related]
17. Facilitation of noradrenaline release from sympathetic nerves in rat anococcygeus muscle by activation of prejunctional beta-adrenoceptors and angiotensin receptors.
Li CG; Majewski H; Rand MJ
Br J Pharmacol; 1988 Oct; 95(2):385-92. PubMed ID: 2852520
[TBL] [Abstract][Full Text] [Related]
18. Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.
Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
Acta Physiol Scand; 1994 Sep; 152(1):83-91. PubMed ID: 7810335
[TBL] [Abstract][Full Text] [Related]
19. Renal 11 beta-hydroxysteroid dehydrogenase activity is enhanced by ramipril and captopril.
Riddle MC; McDaniel PA
J Clin Endocrinol Metab; 1994 Apr; 78(4):830-4. PubMed ID: 8157707
[TBL] [Abstract][Full Text] [Related]
20. Prostacyclin-mediated cardioprotection of captopril and ramiprilate against lipid peroxidation in rat.
Chen X; Pi XJ; Li DY; Li YJ; Deng HW
Prog Clin Biol Res; 1989; 301():167-73. PubMed ID: 2508099
[No Abstract] [Full Text] [Related]
[Next] [New Search]
